Hamza Hashmi
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Oncology 61
- CAR-T cell therapy research 41
- Peptidase Inhibition and Analysis 9
- Hematology 61
- Multiple Myeloma Research and Treatments 48
- Hematopoietic Stem Cell Transplantation 7
- Co-authors
- James A. Davis (36 shared papers)Al‐Ola Abdallah (31 shared papers)Nausheen Ahmed (30 shared papers)Joseph P. McGuirk (16 shared papers)Faiz Anwer (21 shared papers)Jack Khouri (16 shared papers)Danai Dima (17 shared papers)Leyla Shune (13 shared papers)
- Journals
- Blood (20 papers)Transplantation and Cellular Therapy (19 papers)Journal of Clinical Oncology (4 papers)Biology of Blood and Marrow Transplantation (3 papers)European Journal Of Haematology (3 papers)
- Partner nations
- United StatesPakistanIndia
In The Last Decade
Hamza Hashmi
88 papers receiving 472 citations
Peers
Comparison fields: 5 of 66
- Hematology 198
- Oncology 274
- Genetics 44
- Immunology 76
- Molecular Biology 177
Countries citing papers authored by Hamza Hashmi
This map shows the geographic impact of Hamza Hashmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamza Hashmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamza Hashmi more than expected).
Fields of papers citing papers by Hamza Hashmi
This network shows the impact of papers produced by Hamza Hashmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamza Hashmi. The network helps show where Hamza Hashmi may publish in the future.
Co-authors
The 25 scholars most cited alongside Hamza Hashmi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 40 | |
| 2 | 2016 | 35 | |
| 3 | 2020 | 34 | |
| 4 | 2022 | 28 | |
| 5 | 2023 | 27 | |
| 6 | 2023 | 18 | |
| 7 | 2023 | 17 | |
| 8 | 2024 | 11 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 10 | |
| 11 | 2024 | 10 | |
| 12 | 2021 | 10 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 9 | |
| 15 | Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix. | 2016 | 9 |
| 16 | 2023 | 8 | |
| 17 | 2018 | 8 | |
| 18 | 2022 | 7 | |
| 19 | 2020 | 7 | |
| 20 | 2021 | 7 |
About Hamza Hashmi
Hamza Hashmi is a scholar working on Oncology, Hematology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 102 papers that have together received 476 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (48 papers), CAR-T cell therapy research (41 papers), Protein Degradation and Inhibitors (17 papers), Peptidase Inhibition and Analysis (9 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (8 papers), Hematopoietic Stem Cell Transplantation (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Hematology (198 citations), Oncology (274 citations), Genetics (44 citations), Immunology (76 citations) and Molecular Biology (177 citations). Hamza Hashmi has collaborated with scholars based in United States, Pakistan and India. Frequent co-authors include James A. Davis, Al‐Ola Abdallah, Nausheen Ahmed, Joseph P. McGuirk, Faiz Anwer, Jack Khouri, Danai Dima, Leyla Shune, Shahzad Raza and Taiga Nishihori. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Journal of Clinical Oncology, Biology of Blood and Marrow Transplantation and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.